TP53 and cancer: Collectively, these findings demonstrate that notwithstanding that SCO2 is likely to play a major role in p53‐dependent metabolic reprogramming and thus determine the fate of cancer cells, the underpinning mechanisms and associated clinical correlates remain incompletely understood.